India approves its first dengue vaccine, from Japan's Takeda
Biotech
Why It Matters
This Biotech development strengthens the region's biomanufacturing and life-sciences base. For Japan, it is a signal worth tracking: it shapes who supplies, who scales, and who sets the standard over the next five years.
Key Facts
- SectorBiotech
- MarketJapan
- ImpactMedium (56/100)
- SignalNews